NEO

NEO Total Liabilities

$565.65MQuarterly · USD

Period ending:

NEO FY Total LiabilitiesUSD
NEO FY Total Liabilities2000-12-31: $125.03K2001-12-31: $186.22K2002-12-31: $424.49K2003-12-31: $874.84K2004-12-31: $1.02M2005-12-31: $2.08M2006-12-31: $3.08M2007-12-31: $4.20M2008-12-31: $5.79M2009-12-31: $7.30M2010-12-31: $10.52M2011-12-31: $14.05M2012-12-31: $20.86M2013-12-31: $18.21M2014-12-31: $20.70M2015-12-31: $129.84M2016-12-31: $150.52M2017-12-31: $137.81M2018-12-31: $184.57M2019-12-31: $202.10M2020-12-31: $294.04M2021-12-31: $761.50M2022-12-31: $742.01M2023-12-31: $739.69M2024-12-31: $735.70M2025-12-31: $523.27M$761.50M$0.00
2000-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NEO total liabilities history

Total amount the company owes to creditors. The available annual fiscal periods series contains 26 observations from Dec 31, 2000 to Dec 31, 2025.

Neogenomics Inc Total Liabilities — Annual fiscal periods (USD)
Period endingTotal Liabilities (USD)
523,268,000
735,699,000
739,692,000
742,011,000
761,501,000
294,037,000
202,098,000
184,572,000
137,807,000
150,522,000
129,843,000
20,701,000
18,205,000
20,855,000
14,052,000
10,516,000
7,301,961
5,794,265
4,198,786
3,077,434
2,075,043
1,018,654
874,841
424,494
186,216
125,029

Compare total liabilities

All NEO financial metrics · NEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.